John S. Bradley, MD, FAAP, FIDSA

John Bradley completed his pediatric infectious diseases training at Stanford University in 1981 and spends his time divided between clinical medicine and clinical research. His clinical research priorities are the development of effective therapy for both multi-drug resistant Gram-negative bacilli and for CA-MRSA invasive infections- using pharmacodynamic/pharmacokinetic modeling for dose optimization. He is a professor and chief of the Division of Infectious Diseases in the Department of Pediatrics at UCSD, and the director of the Division of Infectious Diseases at Rady Children’s Hospital San Diego. He served on the FDA’s Anti-Infectives Advisory Drug Committee, and continues currently as an advisor. He has participated in improving pediatric clinical trial design with the Foundation of the NIH, the Duke/FDA/Pharma Clinical Trials Transformation Initiative and the Critical Path’s Pediatric Trials Consortium. He recently served as an associate editor of the Pediatric Infectious Diseases Journal, and is the senior editor of the Nelson’s Pediatric Antimicrobial Therapy, published by the AAP.